<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02640131</url>
  </required_header>
  <id_info>
    <org_study_id>701840</org_study_id>
    <secondary_id>701840</secondary_id>
    <nct_id>NCT02640131</nct_id>
  </id_info>
  <brief_title>A Bio-psychosocial Sexual Health Intervention for Prostate Cancer Survivors and Partners: a Feasibility Study</brief_title>
  <acronym>BSHR</acronym>
  <official_title>A Bio-psychosocial Sexual Health Intervention for Prostate Cancer Survivors and Partners: a Feasibility Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Health Network, Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The burden of sexual dysfunction after prostate cancer surgery is responsible for the single
      greatest impact on patient/partner health-related quality of life; substantially more so than
      concern for cancer recurrence, or any other post-surgery side-effect. Consequently, there is
      a great need for progressive and distributable sexual health rehabilitation interventions
      designed to uphold intimacy and optimal sexual health. If the biomedical-psychosocial
      intervention is ultimately found beneficial, it will result in: 1) an empirically-based
      intervention that helps patients/partners maintain optimal health-related quality of life
      after prostate cancer surgery, and 2) a highly structured protocol and manualized
      intervention that is translatable to other treatment groups (e.g. radiation therapy) and
      University/Community-based hospitals.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Previous Research: The prevalence of sexual dysfunction (SD) after prostate cancer surgery,
      coupled with the severity of impact and lack of successful intervention, make SD one of the
      most substantial health-related quality of life burdens in all of cancer survivorship. In
      2012, 21,000 men will be added to the pool of Canadian prostate cancer (PC) survivors.
      Approximately 70% of men will suffer SD post-surgery and 60% will experience significant
      distress in response to SD. Similarly, partners may experience even greater distress than
      patients. Research examining the nature of the distress reveals that the significance of SD
      extends beyond the ability to have an erection, and includes guilt, depression, anxiety,
      anger, and reductions in intimacy. Unfortunately, there are no reported interventions that
      have been successful in reducing the impact of SD on long term couple health-related quality
      of life.

      Project Description: Men and their partners need an effective intervention to help them adapt
      to sexual dysfunction following prostate cancer surgery. In addressing this need we propose
      an innovative biomedical-psychosocial Intervention that emphasizes: 1) multidisciplinary
      intervention teams; 2) the active participation of the partner; and 3) a broad-spectrum
      medical, psychological, and social approach. The treatment goal of the intervention is to
      promote intimacy and optimal sexual health in affected couples. This is a preliminary study
      designed to determine the feasibility of running a large scale randomized controlled trial
      comparing the new biomedical-psychosocial intervention to an attention control condition.

      Impact and Relevance: The burden of sexual dysfunction after prostate cancer surgery is
      responsible for the single greatest impact on patient/partner health-related quality of life;
      substantially more so than concern for cancer recurrence, or any other post-surgery
      side-effect. Consequently, there is a great need for progressive and distributable sexual
      health rehabilitation interventions designed to uphold intimacy and optimal sexual health. If
      the biomedical-psychosocial intervention is ultimately found beneficial, it will result in:
      1) an empirically-based intervention that helps patients/partners maintain optimal
      health-related quality of life after prostate cancer surgery, and 2) a highly structured
      protocol and manualized intervention that is translatable to other treatment groups (e.g.
      radiation therapy) and University/Community-based hospitals.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Actual">May 2017</completion_date>
  <primary_completion_date type="Actual">January 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Miller Social Intimacy Scale (MSIS)</measure>
    <time_frame>At least 1 week prior to radical prostatectomy; 13-14 months post-radical prostatectomy</time_frame>
    <description>MSIS is a questionnaire for intimacy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>International Index of Erectile Function (IIEF)</measure>
    <time_frame>At least one week prior to radical prostatectomy; 13-14 months post-radical prostatectomy</time_frame>
    <description>IIEF is a questionnaire for male sexual function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Female Sexual Function Inventory (FSFI)</measure>
    <time_frame>At least one week prior to radical prostatectomy; 13-14 months post-radical prostatectomy</time_frame>
    <description>FSFI is a questionnaire for female sexual function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Anxiety and Depression Scale (HADS)</measure>
    <time_frame>At least one week prior to radical prostatectomy; 13-14 months post-radical prostatectomy</time_frame>
    <description>HADS is questionnaire for anxiety and depression</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS)</measure>
    <time_frame>13-14 months post-radical prostatectomy</time_frame>
    <description>EDITS is questionnaire for the satisfaction of treatment for erectile dysfunction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sexual Health Rehabilitation Record</measure>
    <time_frame>3-4 months post-radical prostatectomy;7-8 months post-radical prostatectomy;12-13 months post-radical prostatectomy</time_frame>
    <description>*investigator designed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Expanded Prostate Cancer Index Composite (EPIC)</measure>
    <time_frame>At least 1 week prior to radical prostatectomy; 13-14 months post-radical prostatectomy</time_frame>
    <description>Expanded Prostate Cancer Index Composite (EPIC) is a comprehensive instrument designed to evaluate patient function and bother after prostate cancer treatment.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">65</enrollment>
  <condition>Prostate Cancer</condition>
  <condition>Erectile Dysfunction</condition>
  <condition>Sexual Dysfunction</condition>
  <arm_group>
    <arm_group_label>BSHR Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Couples will attend 30-minute clinic consultations with an Urologist and a Sexual Health Counsellor and receive session-specific chapters of the Kindness, Intimacy, Sexuality and Satisfaction manual over the course of the intervention.
The BSHR Intervention involves two complementary components; the bio-medical, and the psychosocial. The bio-medical component for both arms intervention includes an urologist consultation at a pre-operative appointment and 5 f/u appointments. Patients/partners are provided instruction on the use of pro-erectile agents/devices.
The psychosocial component aims to support maintenance of intimacy, pro-erectile therapy use, and regular satisfying sexual activity. At each time point, participants receive sexual health counseling and manualized support.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Attention Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Survivorship Counseling: Couples will attend 30-minute clinic consultations with an Urologist and a Survivorship Counsellor (SurvC) and receive a Kegel Exercise booklet and receive appointment-specific chapters of the Challenging Prostate Cancer: &quot;Nutrition, Exercise, and You Manual&quot;. The bio-medical component is the same in both arms.
The core topics discussed during over 7 counseling sessions include: preparation for immediate post-surgery recovery, Kegel exercises, nutrition and prostate cancer, exercise and prostate cancer, and maintaining healthy lifestyle change.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Biomedical Component</intervention_name>
    <description>Bio-medical: The bio-medical component includes an appointment with urologist pre-operatively and 5 follow-up appointments. Patients/partners are provided instruction on the use of pro-erectile agents/devices.</description>
    <arm_group_label>BSHR Intervention</arm_group_label>
    <arm_group_label>Attention Control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Psychosocial Component</intervention_name>
    <description>Psychosocial: aims to support maintenance of intimacy, pro-erectile therapy use, and regular satisfying sexual activity. At each time point, participants receive standardized sexual health counselor (SexHC) counseling and manualized support.</description>
    <arm_group_label>BSHR Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Attention Control</intervention_name>
    <description>Couples will attend 30-minute clinic consultations with an Urologist and a Survivorship Counsellor (SurvC) at 3-4, 7-8, and 12-13 months post radical prostatectomy (RP). Couples will receive a Kegel Exercise booklet and receive appointment-specific chapters of the Challenging Prostate Cancer: Nutrition, Exercise, and You (CPC) manual (a patient self-help manual written by the Princess Margaret Prostate Centre team). The core topics discussed during the counselling sessions include: preparation for immediate post-RP recovery, Kegel exercises, nutrition and prostate cancer (PC), exercise and PC, and maintaining healthy lifestyle change.</description>
    <arm_group_label>Attention Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  scheduled for a Radical Prostatectomy at the Princess Margaret Cancer Centre(open,
             laparoscopic, robotic) for the first-line treatment of prostate cancer regardless of
             clinical stage of disease

          -  are hormone and/or chemotherapy-na√Øve

          -  have a sexual partner (heterosexual or homosexual) for at least the past 6 months

          -  are 18 years of age or older

          -  Partners of men who meet the above criteria and are 18 years of age or older

        Exclusion Criteria:

          -  the patient or partner lacks English proficiency

          -  the patient is on nitrate therapy or has other contra-indications to phosphodiesterase
             type 5 inhibitors (PDE5i's)

          -  the patient does not have a sexual partner

          -  the patient or partner has a medical condition that would preclude safe sexual
             activity

          -  the patient has had previous treatment for PC

          -  the patient has previously and regularly used sexual aids/devices during the course of
             sexual activity
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrew G Matthew, PhD, C.Psych</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Health Network, Toronto</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Prostate Centre, Princess Margaret Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2M9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 28, 2014</study_first_submitted>
  <study_first_submitted_qc>December 21, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 28, 2015</study_first_posted>
  <last_update_submitted>May 9, 2018</last_update_submitted>
  <last_update_submitted_qc>May 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>prostate cancer</keyword>
  <keyword>radical prostatectomy</keyword>
  <keyword>survivorship</keyword>
  <keyword>quality of life</keyword>
  <keyword>erectile dysfunction</keyword>
  <keyword>sexual dysfunction</keyword>
  <keyword>feasibility study</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
    <mesh_term>Erectile Dysfunction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

